Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients

BACKGROUND: Venous thromboembolism (VTE) can be encountered by 60% of hospitalized patients. Anticoagulants have been recommended to reduce the risk of VTE in patients with risk factors. However, no specific dosing recommendations for obese patients are provided in the current practice guidelines. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Otaib, Nouf, Bootah, Zohour, Al Ammari, Maha A., Aldebasi, Tariq M., Alkatheri, Abdulmalik M., Al Harbi, Shmeylan A., AbuRuz, Salah M., AlBekairy, Abdulkareem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541968/
https://www.ncbi.nlm.nih.gov/pubmed/28808492
http://dx.doi.org/10.4103/atm.ATM_31_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541968/
https://www.ncbi.nlm.nih.gov/pubmed/28808492
http://dx.doi.org/10.4103/atm.ATM_31_17

Ejemplares similares